Overview

Blood and Marrow Transplant Clinical Research Network

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.
Phase:
N/A
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator:
Blood and Marrow Transplant Clinical Trials Network
Treatments:
Dexamethasone
Fluconazole
Thalidomide
Voriconazole